Last reviewed · How we verify
TCM prescriptions
At a glance
| Generic name | TCM prescriptions |
|---|---|
| Sponsor | Jiangsu Famous Medical Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease (NA)
- YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer (NA)
- Parent-administered Pediatric Tuina Versus Routine Care for Pediatric Functional Dyspepsia (NA)
- Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial (PHASE1)
- Pilot Trial of XFBD, a TCM, in Persons With COVID-19 (PHASE2)
- Clinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Patients Undergoing Chemotherapy (NA)
- Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain (NA)
- Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TCM prescriptions CI brief — competitive landscape report
- TCM prescriptions updates RSS · CI watch RSS
- Jiangsu Famous Medical Technology Co., Ltd. portfolio CI